HansBurr9101: /* Cases */ I don't see the point of this {{clear}} template

2023-10-12T14:43:20Z

Cases: I don't see the point of this {{clear}} template

← Older revision		Revision as of 20:13, 12 October 2023
Line 122:		Line 122:

	In December 2021, the number of cases continued to climb due to several factors, including new COVID-19 variants. As of that 28{{nbsp}}December, 282,790,822 individuals worldwide had been confirmed as infected.<ref>{{#invoke:cite web \|\|title=ArcGIS Dashboards \|url=https://gisanddata.maps.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6 \|publisher=gisanddata.maps.arcgis.com \|access-date=22 December 2021}}</ref> {{As of \|2022\|April\|14}}, over 500 million cases were confirmed globally.<ref>{{#invoke:cite web \|\|last1=B \|first1=Kavya \|last2=Mazumder \|first2=Aparupa \| name-list-style = vanc \|title=Worldwide COVID cases surpass 500 mln as Omicron variant BA.2 surges \|url=https://www.reuters.com/business/healthcare-pharmaceuticals/worldwide-covid-cases-surpass-500-mln-omicron-variant-ba2-surges-2022-04-14/ \|website=Reuters \|access-date=21 April 2022 \|language=en \|date=14 April 2022}}</ref> Most cases are unconfirmed, with the [[Institute for Health Metrics and Evaluation]] estimating the true number of cases as of early 2022 to be in the billions.<ref name="57percent1" /><ref name="57percent2" />		In December 2021, the number of cases continued to climb due to several factors, including new COVID-19 variants. As of that 28{{nbsp}}December, 282,790,822 individuals worldwide had been confirmed as infected.<ref>{{#invoke:cite web \|\|title=ArcGIS Dashboards \|url=https://gisanddata.maps.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6 \|publisher=gisanddata.maps.arcgis.com \|access-date=22 December 2021}}</ref> {{As of \|2022\|April\|14}}, over 500 million cases were confirmed globally.<ref>{{#invoke:cite web \|\|last1=B \|first1=Kavya \|last2=Mazumder \|first2=Aparupa \| name-list-style = vanc \|title=Worldwide COVID cases surpass 500 mln as Omicron variant BA.2 surges \|url=https://www.reuters.com/business/healthcare-pharmaceuticals/worldwide-covid-cases-surpass-500-mln-omicron-variant-ba2-surges-2022-04-14/ \|website=Reuters \|access-date=21 April 2022 \|language=en \|date=14 April 2022}}</ref> Most cases are unconfirmed, with the [[Institute for Health Metrics and Evaluation]] estimating the true number of cases as of early 2022 to be in the billions.<ref name="57percent1" /><ref name="57percent2" />
	~~{{clear}}~~

	[[File:Covid-19 new cases in top 5 countries and the world.png\|thumb\|center\|400px\|Semi-log plot of weekly new cases of COVID-19 in the world and the current top six countries (mean with deaths)]]		[[File:Covid-19 new cases in top 5 countries and the world.png\|thumb\|center\|400px\|Semi-log plot of weekly new cases of COVID-19 in the world and the current top six countries (mean with deaths)]]
Line 393:		Line 392:
	===2023===		===2023===
	{{Hatnote\|[[Timeline of the COVID-19 pandemic in 2023]]}}		{{Hatnote\|[[Timeline of the COVID-19 pandemic in 2023]]}}
	On 4 January 2023, the World Health Organization said the information shared by China during the recent surge in infections lacked data, such as hospitalization rates.<ref>{{#invoke:cite web \|\|title=WHO worried about surge of COVID in China amid lack of info \|url=https://apnews.com/article/health-china-covid-19-pandemic-world-organization-2576d9c8c1c1f75b76800edbb476894d \|website=AP NEWS \|access-date=6 January 2023 \|language=en \|date=4 January 2023}}</ref> On 10 January, the ~~WHO’s~~ Europe office said the recent viral surge in China posed "no immediate threat."<ref>{{#invoke:cite news \|\|title=WHO Europe: no immediate COVID-19 threat from China \|url=https://apnews.com/article/health-covid-19-pandemic-china-europe-world-organization-2cead41e96c46b8027c26510bddb0873 \|access-date=31 May 2023 \|work=AP NEWS \|date=10 January 2023 \|language=en}}</ref> On 16 January, the WHO recommended that China monitor excess mortality to provide "a more comprehensive understanding of the impact of COVID-19."<ref>{{#invoke:cite news \|\|last1=Tétrault-Farber \|first1=Gabrielle \|last2=Rigby \|first2=Jennifer \|last3=Farge \|first3=Emma \|title=WHO recommends that China monitor excess COVID-19 mortality \|url=https://www.reuters.com/world/china/who-recommends-that-china-monitor-excess-covid-19-mortality-2023-01-16/ \|access-date=31 May 2023 \|work=Reuters \|date=16 January 2023 \|language=en}}</ref>		On 4 January 2023, the World Health Organization said the information shared by China during the recent surge in infections lacked data, such as hospitalization rates.<ref>{{#invoke:cite web \|\|title=WHO worried about surge of COVID in China amid lack of info \|url=https://apnews.com/article/health-china-covid-19-pandemic-world-organization-2576d9c8c1c1f75b76800edbb476894d \|website=AP NEWS \|access-date=6 January 2023 \|language=en \|date=4 January 2023}}</ref> On 10 January, the WHO's Europe office said the recent viral surge in China posed "no immediate threat."<ref>{{#invoke:cite news \|\|title=WHO Europe: no immediate COVID-19 threat from China \|url=https://apnews.com/article/health-covid-19-pandemic-china-europe-world-organization-2cead41e96c46b8027c26510bddb0873 \|access-date=31 May 2023 \|work=AP NEWS \|date=10 January 2023 \|language=en}}</ref> On 16 January, the WHO recommended that China monitor excess mortality to provide "a more comprehensive understanding of the impact of COVID-19."<ref>{{#invoke:cite news \|\|last1=Tétrault-Farber \|first1=Gabrielle \|last2=Rigby \|first2=Jennifer \|last3=Farge \|first3=Emma \|title=WHO recommends that China monitor excess COVID-19 mortality \|url=https://www.reuters.com/world/china/who-recommends-that-china-monitor-excess-covid-19-mortality-2023-01-16/ \|access-date=31 May 2023 \|work=Reuters \|date=16 January 2023 \|language=en}}</ref>

	On 30 January, the three-year anniversary of the original declaration, the World Health Organization determined that COVID-19 still met the criteria for a public health emergency of international concern (PHEIC).<ref>{{#invoke:cite news \|\|last1=Lasarte \|first1=Diego \|last2=Sofia \|first2=Lotto Persio \|title=China's covid cases loom over upcoming WHO meeting on state of the pandemic \|url=https://qz.com/covid-pandemic-public-health-emergency-end-who-1850035035 \|access-date=31 May 2023 \|work=Quartz \|date=26 January 2023 \|language=en}}</ref>		On 30 January, the three-year anniversary of the original declaration, the World Health Organization determined that COVID-19 still met the criteria for a public health emergency of international concern (PHEIC).<ref>{{#invoke:cite news \|\|last1=Lasarte \|first1=Diego \|last2=Sofia \|first2=Lotto Persio \|title=China's covid cases loom over upcoming WHO meeting on state of the pandemic \|url=https://qz.com/covid-pandemic-public-health-emergency-end-who-1850035035 \|access-date=31 May 2023 \|work=Quartz \|date=26 January 2023 \|language=en}}</ref>
Line 673:		Line 672:
	In June 2022, an article in ''[[Human Genome Organisation\|Human Genomics]]'' said that the pandemic was still "raging", but that "now is the time to explore the transition from the pandemic to the endemic phase."<ref>{{#invoke:cite journal\|\|doi=10.1186/s40246-022-00392-1\|title=COVID-19 2022 update: Transition of the pandemic to the endemic phase\|year=2022\|last1=Biancolella\|first1=Michela\|last2=Colona\|first2=Vito Luigi\|last3=Mehrian-Shai\|first3=Ruty\|last4=Watt\|first4=Jessica Lee\|last5=Luzzatto\|first5=Lucio\|last6=Novelli\|first6=Giuseppe\|last7=Reichardt\|first7=Juergen K. V.\|journal=Human Genomics\|volume=16\|issue=1\|page=19\|pmid=35650595\|pmc=9156835\|s2cid=249274308}}</ref>		In June 2022, an article in ''[[Human Genome Organisation\|Human Genomics]]'' said that the pandemic was still "raging", but that "now is the time to explore the transition from the pandemic to the endemic phase."<ref>{{#invoke:cite journal\|\|doi=10.1186/s40246-022-00392-1\|title=COVID-19 2022 update: Transition of the pandemic to the endemic phase\|year=2022\|last1=Biancolella\|first1=Michela\|last2=Colona\|first2=Vito Luigi\|last3=Mehrian-Shai\|first3=Ruty\|last4=Watt\|first4=Jessica Lee\|last5=Luzzatto\|first5=Lucio\|last6=Novelli\|first6=Giuseppe\|last7=Reichardt\|first7=Juergen K. V.\|journal=Human Genomics\|volume=16\|issue=1\|page=19\|pmid=35650595\|pmc=9156835\|s2cid=249274308}}</ref>

	A March 2022 review declared the transition to endemic status to be "inevitable".<ref>{{Cite journal \|last1=Koelle \|first1=Katia \|last2=Martin \|first2=Michael A. \|last3=Antia \|first3=Rustom \|last4=Lopman \|first4=Ben \|last5=Dean \|first5=Natalie E. \|date=11 March 2022 \|title=The changing epidemiology of SARS-CoV-2 \|journal=Science \|volume=375 \|issue=6585 \|pages=1116–1121 \|doi=10.1126/science.abm4915 \|issn=1095-9203 \|pmc=9009722 \|pmid=35271324\|bibcode=2022Sci...375.1116K }}</ref> A June 2022 review predicted that the virus that causes COVID-19 would become the fifth endemic seasonal coronavirus, alongside four other [[HCoV\|human coronaviruses]].<ref>{{cite journal \|last1=Cohen \|first1=Lily E. \|last2=Spiro \|first2=David J. \|last3=Viboud \|first3=Cecile \|date=30 June 2022 \|title=Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations \|journal=PLOS Pathogens \|language=en \|volume=18 \|issue=6 \|pages=e1010591 \|doi=10.1371/journal.ppat.1010591 \|issn=1553-7374 \|pmid=35771775 \|pmc=9246171 \|doi-access=free }}</ref> A February 2023 review of the four [[common cold]] coronaviruses concluded that the virus would become seasonal and, like the common cold, cause less severe disease for most people.<ref>{{cite journal \|last1=Harrison \|first1=Cameron M. \|last2=Doster \|first2=Jayden M. \|last3=Landwehr \|first3=Emily H. \|last4=Kumar \|first4=Nidhi P. \|last5=White \|first5=Ethan J. \|last6=Beachboard \|first6=Dia C. \|last7=Stobart \|first7=Christopher C. \|title=Evaluating the Virology and Evolution of Seasonal Human Coronaviruses Associated with the Common Cold in the COVID-19 Era \|journal=Microorganisms \|date=10 February 2023 \|volume=11 \|issue=2 \|pages=445 \|doi=10.3390/microorganisms11020445 \|pmid=36838410 \|pmc=9961755 \|issn=2076-2607 \|quote=After evaluating the biology, pathogenesis, and emergence of the human coronaviruses that cause the common cold, we can anticipate that with increased vaccine immunity to SARS-CoV-2, it will become a seasonal, endemic coronavirus that causes less severe disease in most individuals. Much like the common cold CoVs, the potential for severe disease will likely be present in those who lack a protective immune response or are immunocompromised. \|doi-access=free }}</ref> {{~~asof~~\|2023}} the transition to endemic COVID-19 may take years or decades.<ref>{{cite journal \|vauthors=Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis NI, Katzourakis A \|title=The evolution of SARS-CoV-2 \|journal=Nat Rev Microbiol \|volume=21 \|issue=6 \|pages=361–379 \|date=June 2023 \|pmid=37020110 \|doi=10.1038/s41579-023-00878-2 \|s2cid=257983412 \|type=Review}}</ref>		A March 2022 review declared the transition to endemic status to be "inevitable".<ref>{{Cite journal \|last1=Koelle \|first1=Katia \|last2=Martin \|first2=Michael A. \|last3=Antia \|first3=Rustom \|last4=Lopman \|first4=Ben \|last5=Dean \|first5=Natalie E. \|date=11 March 2022 \|title=The changing epidemiology of SARS-CoV-2 \|journal=Science \|volume=375 \|issue=6585 \|pages=1116–1121 \|doi=10.1126/science.abm4915 \|issn=1095-9203 \|pmc=9009722 \|pmid=35271324\|bibcode=2022Sci...375.1116K }}</ref> A June 2022 review predicted that the virus that causes COVID-19 would become the fifth endemic seasonal coronavirus, alongside four other [[HCoV\|human coronaviruses]].<ref>{{cite journal \|last1=Cohen \|first1=Lily E. \|last2=Spiro \|first2=David J. \|last3=Viboud \|first3=Cecile \|date=30 June 2022 \|title=Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations \|journal=PLOS Pathogens \|language=en \|volume=18 \|issue=6 \|pages=e1010591 \|doi=10.1371/journal.ppat.1010591 \|issn=1553-7374 \|pmid=35771775 \|pmc=9246171 \|doi-access=free }}</ref> A February 2023 review of the four [[common cold]] coronaviruses concluded that the virus would become seasonal and, like the common cold, cause less severe disease for most people.<ref>{{cite journal \|last1=Harrison \|first1=Cameron M. \|last2=Doster \|first2=Jayden M. \|last3=Landwehr \|first3=Emily H. \|last4=Kumar \|first4=Nidhi P. \|last5=White \|first5=Ethan J. \|last6=Beachboard \|first6=Dia C. \|last7=Stobart \|first7=Christopher C. \|title=Evaluating the Virology and Evolution of Seasonal Human Coronaviruses Associated with the Common Cold in the COVID-19 Era \|journal=Microorganisms \|date=10 February 2023 \|volume=11 \|issue=2 \|pages=445 \|doi=10.3390/microorganisms11020445 \|pmid=36838410 \|pmc=9961755 \|issn=2076-2607 \|quote=After evaluating the biology, pathogenesis, and emergence of the human coronaviruses that cause the common cold, we can anticipate that with increased vaccine immunity to SARS-CoV-2, it will become a seasonal, endemic coronavirus that causes less severe disease in most individuals. Much like the common cold CoVs, the potential for severe disease will likely be present in those who lack a protective immune response or are immunocompromised. \|doi-access=free }}</ref> {{as of\|2023}} the transition to endemic COVID-19 may take years or decades.<ref>{{cite journal \|vauthors=Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis NI, Katzourakis A \|title=The evolution of SARS-CoV-2 \|journal=Nat Rev Microbiol \|volume=21 \|issue=6 \|pages=361–379 \|date=June 2023 \|pmid=37020110 \|doi=10.1038/s41579-023-00878-2 \|s2cid=257983412 \|type=Review}}</ref>

	== Long-term effects ==		== Long-term effects ==

Xuppi: Cleaned up

2023-10-06T18:35:43Z

Cleaned up

← Older revision	Revision as of 00:05, 7 October 2023
(No difference)

Xuppi: Cleaned up

2023-10-06T18:35:43Z

Cleaned up

Show changes

2A02:21B0:644D:B92F:78D6:7F59:F477:3FCC: robot: Trimming article to decrease server load

2022-10-14T17:58:57Z

robot: Trimming article to decrease server load

← Older revision	Revision as of 23:28, 14 October 2022
(No difference)

2A02:21B0:644D:B92F:78D6:7F59:F477:3FCC: robot: Trimming article to decrease server load

2022-10-14T17:58:57Z

robot: Trimming article to decrease server load

← Older revision	Revision as of 23:28, 14 October 2022
(No difference)

2A02:21B0:644D:B92F:78D6:7F59:F477:3FCC: robot: Trimming article to decrease server load

2022-10-14T17:58:57Z

robot: Trimming article to decrease server load

Show changes

UpdateBot: robot: Update article

2022-05-08T11:19:02Z

robot: Update article

Show changes

>Hunenmensch at 07:29, 20 January 2022

2022-01-20T07:29:12Z

Show changes

WikiDwarfBOT: clean up, replaced: Wikipedia: → Bharatpedia:

2021-05-31T11:42:53Z

clean up, replaced: Wikipedia: → Bharatpedia:

Show changes

WikiDwarfBOT: /* Other websites */Replace {{Source}} tag

2021-04-30T14:22:44Z

Other websites: Replace {{Source}} tag

← Older revision		Revision as of 19:52, 30 April 2021
Line 247:		Line 247:
	* [https://www.who.int/news-room/q-a-detail/q-a-coronaviruses WHO questions on COVID-19]		* [https://www.who.int/news-room/q-a-detail/q-a-coronaviruses WHO questions on COVID-19]

	~~{{Source\|Wiki\|S}}~~
	{{2019–20 coronavirus pandemic}}		{{2019–20 coronavirus pandemic}}

Line 271:		Line 271:
	[[Category:March 2021 events]]		[[Category:March 2021 events]]
	[[Category:April 2021 events]]		[[Category:April 2021 events]]


			{{simple-Wikipedia}}

← Older revision		Revision as of 20:13, 12 October 2023
Line 122:		Line 122:

	In December 2021, the number of cases continued to climb due to several factors, including new COVID-19 variants. As of that 28{{nbsp}}December, 282,790,822 individuals worldwide had been confirmed as infected.<ref>{{#invoke:cite web \|\|title=ArcGIS Dashboards \|url=https://gisanddata.maps.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6 \|publisher=gisanddata.maps.arcgis.com \|access-date=22 December 2021}}</ref> {{As of \|2022\|April\|14}}, over 500 million cases were confirmed globally.<ref>{{#invoke:cite web \|\|last1=B \|first1=Kavya \|last2=Mazumder \|first2=Aparupa \| name-list-style = vanc \|title=Worldwide COVID cases surpass 500 mln as Omicron variant BA.2 surges \|url=https://www.reuters.com/business/healthcare-pharmaceuticals/worldwide-covid-cases-surpass-500-mln-omicron-variant-ba2-surges-2022-04-14/ \|website=Reuters \|access-date=21 April 2022 \|language=en \|date=14 April 2022}}</ref> Most cases are unconfirmed, with the [[Institute for Health Metrics and Evaluation]] estimating the true number of cases as of early 2022 to be in the billions.<ref name="57percent1" /><ref name="57percent2" />		In December 2021, the number of cases continued to climb due to several factors, including new COVID-19 variants. As of that 28{{nbsp}}December, 282,790,822 individuals worldwide had been confirmed as infected.<ref>{{#invoke:cite web \|\|title=ArcGIS Dashboards \|url=https://gisanddata.maps.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6 \|publisher=gisanddata.maps.arcgis.com \|access-date=22 December 2021}}</ref> {{As of \|2022\|April\|14}}, over 500 million cases were confirmed globally.<ref>{{#invoke:cite web \|\|last1=B \|first1=Kavya \|last2=Mazumder \|first2=Aparupa \| name-list-style = vanc \|title=Worldwide COVID cases surpass 500 mln as Omicron variant BA.2 surges \|url=https://www.reuters.com/business/healthcare-pharmaceuticals/worldwide-covid-cases-surpass-500-mln-omicron-variant-ba2-surges-2022-04-14/ \|website=Reuters \|access-date=21 April 2022 \|language=en \|date=14 April 2022}}</ref> Most cases are unconfirmed, with the [[Institute for Health Metrics and Evaluation]] estimating the true number of cases as of early 2022 to be in the billions.<ref name="57percent1" /><ref name="57percent2" />
	~~{{clear}}~~

	[[File:Covid-19 new cases in top 5 countries and the world.png\|thumb\|center\|400px\|Semi-log plot of weekly new cases of COVID-19 in the world and the current top six countries (mean with deaths)]]		[[File:Covid-19 new cases in top 5 countries and the world.png\|thumb\|center\|400px\|Semi-log plot of weekly new cases of COVID-19 in the world and the current top six countries (mean with deaths)]]
Line 393:		Line 392:
	===2023===		===2023===
	{{Hatnote\|[[Timeline of the COVID-19 pandemic in 2023]]}}		{{Hatnote\|[[Timeline of the COVID-19 pandemic in 2023]]}}
	On 4 January 2023, the World Health Organization said the information shared by China during the recent surge in infections lacked data, such as hospitalization rates.<ref>{{#invoke:cite web \|\|title=WHO worried about surge of COVID in China amid lack of info \|url=https://apnews.com/article/health-china-covid-19-pandemic-world-organization-2576d9c8c1c1f75b76800edbb476894d \|website=AP NEWS \|access-date=6 January 2023 \|language=en \|date=4 January 2023}}</ref> On 10 January, the ~~WHO’s~~ Europe office said the recent viral surge in China posed "no immediate threat."<ref>{{#invoke:cite news \|\|title=WHO Europe: no immediate COVID-19 threat from China \|url=https://apnews.com/article/health-covid-19-pandemic-china-europe-world-organization-2cead41e96c46b8027c26510bddb0873 \|access-date=31 May 2023 \|work=AP NEWS \|date=10 January 2023 \|language=en}}</ref> On 16 January, the WHO recommended that China monitor excess mortality to provide "a more comprehensive understanding of the impact of COVID-19."<ref>{{#invoke:cite news \|\|last1=Tétrault-Farber \|first1=Gabrielle \|last2=Rigby \|first2=Jennifer \|last3=Farge \|first3=Emma \|title=WHO recommends that China monitor excess COVID-19 mortality \|url=https://www.reuters.com/world/china/who-recommends-that-china-monitor-excess-covid-19-mortality-2023-01-16/ \|access-date=31 May 2023 \|work=Reuters \|date=16 January 2023 \|language=en}}</ref>		On 4 January 2023, the World Health Organization said the information shared by China during the recent surge in infections lacked data, such as hospitalization rates.<ref>{{#invoke:cite web \|\|title=WHO worried about surge of COVID in China amid lack of info \|url=https://apnews.com/article/health-china-covid-19-pandemic-world-organization-2576d9c8c1c1f75b76800edbb476894d \|website=AP NEWS \|access-date=6 January 2023 \|language=en \|date=4 January 2023}}</ref> On 10 January, the WHO's Europe office said the recent viral surge in China posed "no immediate threat."<ref>{{#invoke:cite news \|\|title=WHO Europe: no immediate COVID-19 threat from China \|url=https://apnews.com/article/health-covid-19-pandemic-china-europe-world-organization-2cead41e96c46b8027c26510bddb0873 \|access-date=31 May 2023 \|work=AP NEWS \|date=10 January 2023 \|language=en}}</ref> On 16 January, the WHO recommended that China monitor excess mortality to provide "a more comprehensive understanding of the impact of COVID-19."<ref>{{#invoke:cite news \|\|last1=Tétrault-Farber \|first1=Gabrielle \|last2=Rigby \|first2=Jennifer \|last3=Farge \|first3=Emma \|title=WHO recommends that China monitor excess COVID-19 mortality \|url=https://www.reuters.com/world/china/who-recommends-that-china-monitor-excess-covid-19-mortality-2023-01-16/ \|access-date=31 May 2023 \|work=Reuters \|date=16 January 2023 \|language=en}}</ref>

	On 30 January, the three-year anniversary of the original declaration, the World Health Organization determined that COVID-19 still met the criteria for a public health emergency of international concern (PHEIC).<ref>{{#invoke:cite news \|\|last1=Lasarte \|first1=Diego \|last2=Sofia \|first2=Lotto Persio \|title=China's covid cases loom over upcoming WHO meeting on state of the pandemic \|url=https://qz.com/covid-pandemic-public-health-emergency-end-who-1850035035 \|access-date=31 May 2023 \|work=Quartz \|date=26 January 2023 \|language=en}}</ref>		On 30 January, the three-year anniversary of the original declaration, the World Health Organization determined that COVID-19 still met the criteria for a public health emergency of international concern (PHEIC).<ref>{{#invoke:cite news \|\|last1=Lasarte \|first1=Diego \|last2=Sofia \|first2=Lotto Persio \|title=China's covid cases loom over upcoming WHO meeting on state of the pandemic \|url=https://qz.com/covid-pandemic-public-health-emergency-end-who-1850035035 \|access-date=31 May 2023 \|work=Quartz \|date=26 January 2023 \|language=en}}</ref>
Line 673:		Line 672:
	In June 2022, an article in ''[[Human Genome Organisation\|Human Genomics]]'' said that the pandemic was still "raging", but that "now is the time to explore the transition from the pandemic to the endemic phase."<ref>{{#invoke:cite journal\|\|doi=10.1186/s40246-022-00392-1\|title=COVID-19 2022 update: Transition of the pandemic to the endemic phase\|year=2022\|last1=Biancolella\|first1=Michela\|last2=Colona\|first2=Vito Luigi\|last3=Mehrian-Shai\|first3=Ruty\|last4=Watt\|first4=Jessica Lee\|last5=Luzzatto\|first5=Lucio\|last6=Novelli\|first6=Giuseppe\|last7=Reichardt\|first7=Juergen K. V.\|journal=Human Genomics\|volume=16\|issue=1\|page=19\|pmid=35650595\|pmc=9156835\|s2cid=249274308}}</ref>		In June 2022, an article in ''[[Human Genome Organisation\|Human Genomics]]'' said that the pandemic was still "raging", but that "now is the time to explore the transition from the pandemic to the endemic phase."<ref>{{#invoke:cite journal\|\|doi=10.1186/s40246-022-00392-1\|title=COVID-19 2022 update: Transition of the pandemic to the endemic phase\|year=2022\|last1=Biancolella\|first1=Michela\|last2=Colona\|first2=Vito Luigi\|last3=Mehrian-Shai\|first3=Ruty\|last4=Watt\|first4=Jessica Lee\|last5=Luzzatto\|first5=Lucio\|last6=Novelli\|first6=Giuseppe\|last7=Reichardt\|first7=Juergen K. V.\|journal=Human Genomics\|volume=16\|issue=1\|page=19\|pmid=35650595\|pmc=9156835\|s2cid=249274308}}</ref>

	A March 2022 review declared the transition to endemic status to be "inevitable".<ref>{{Cite journal \|last1=Koelle \|first1=Katia \|last2=Martin \|first2=Michael A. \|last3=Antia \|first3=Rustom \|last4=Lopman \|first4=Ben \|last5=Dean \|first5=Natalie E. \|date=11 March 2022 \|title=The changing epidemiology of SARS-CoV-2 \|journal=Science \|volume=375 \|issue=6585 \|pages=1116–1121 \|doi=10.1126/science.abm4915 \|issn=1095-9203 \|pmc=9009722 \|pmid=35271324\|bibcode=2022Sci...375.1116K }}</ref> A June 2022 review predicted that the virus that causes COVID-19 would become the fifth endemic seasonal coronavirus, alongside four other [[HCoV\|human coronaviruses]].<ref>{{cite journal \|last1=Cohen \|first1=Lily E. \|last2=Spiro \|first2=David J. \|last3=Viboud \|first3=Cecile \|date=30 June 2022 \|title=Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations \|journal=PLOS Pathogens \|language=en \|volume=18 \|issue=6 \|pages=e1010591 \|doi=10.1371/journal.ppat.1010591 \|issn=1553-7374 \|pmid=35771775 \|pmc=9246171 \|doi-access=free }}</ref> A February 2023 review of the four [[common cold]] coronaviruses concluded that the virus would become seasonal and, like the common cold, cause less severe disease for most people.<ref>{{cite journal \|last1=Harrison \|first1=Cameron M. \|last2=Doster \|first2=Jayden M. \|last3=Landwehr \|first3=Emily H. \|last4=Kumar \|first4=Nidhi P. \|last5=White \|first5=Ethan J. \|last6=Beachboard \|first6=Dia C. \|last7=Stobart \|first7=Christopher C. \|title=Evaluating the Virology and Evolution of Seasonal Human Coronaviruses Associated with the Common Cold in the COVID-19 Era \|journal=Microorganisms \|date=10 February 2023 \|volume=11 \|issue=2 \|pages=445 \|doi=10.3390/microorganisms11020445 \|pmid=36838410 \|pmc=9961755 \|issn=2076-2607 \|quote=After evaluating the biology, pathogenesis, and emergence of the human coronaviruses that cause the common cold, we can anticipate that with increased vaccine immunity to SARS-CoV-2, it will become a seasonal, endemic coronavirus that causes less severe disease in most individuals. Much like the common cold CoVs, the potential for severe disease will likely be present in those who lack a protective immune response or are immunocompromised. \|doi-access=free }}</ref> {{~~asof~~\|2023}} the transition to endemic COVID-19 may take years or decades.<ref>{{cite journal \|vauthors=Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis NI, Katzourakis A \|title=The evolution of SARS-CoV-2 \|journal=Nat Rev Microbiol \|volume=21 \|issue=6 \|pages=361–379 \|date=June 2023 \|pmid=37020110 \|doi=10.1038/s41579-023-00878-2 \|s2cid=257983412 \|type=Review}}</ref>		A March 2022 review declared the transition to endemic status to be "inevitable".<ref>{{Cite journal \|last1=Koelle \|first1=Katia \|last2=Martin \|first2=Michael A. \|last3=Antia \|first3=Rustom \|last4=Lopman \|first4=Ben \|last5=Dean \|first5=Natalie E. \|date=11 March 2022 \|title=The changing epidemiology of SARS-CoV-2 \|journal=Science \|volume=375 \|issue=6585 \|pages=1116–1121 \|doi=10.1126/science.abm4915 \|issn=1095-9203 \|pmc=9009722 \|pmid=35271324\|bibcode=2022Sci...375.1116K }}</ref> A June 2022 review predicted that the virus that causes COVID-19 would become the fifth endemic seasonal coronavirus, alongside four other [[HCoV\|human coronaviruses]].<ref>{{cite journal \|last1=Cohen \|first1=Lily E. \|last2=Spiro \|first2=David J. \|last3=Viboud \|first3=Cecile \|date=30 June 2022 \|title=Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations \|journal=PLOS Pathogens \|language=en \|volume=18 \|issue=6 \|pages=e1010591 \|doi=10.1371/journal.ppat.1010591 \|issn=1553-7374 \|pmid=35771775 \|pmc=9246171 \|doi-access=free }}</ref> A February 2023 review of the four [[common cold]] coronaviruses concluded that the virus would become seasonal and, like the common cold, cause less severe disease for most people.<ref>{{cite journal \|last1=Harrison \|first1=Cameron M. \|last2=Doster \|first2=Jayden M. \|last3=Landwehr \|first3=Emily H. \|last4=Kumar \|first4=Nidhi P. \|last5=White \|first5=Ethan J. \|last6=Beachboard \|first6=Dia C. \|last7=Stobart \|first7=Christopher C. \|title=Evaluating the Virology and Evolution of Seasonal Human Coronaviruses Associated with the Common Cold in the COVID-19 Era \|journal=Microorganisms \|date=10 February 2023 \|volume=11 \|issue=2 \|pages=445 \|doi=10.3390/microorganisms11020445 \|pmid=36838410 \|pmc=9961755 \|issn=2076-2607 \|quote=After evaluating the biology, pathogenesis, and emergence of the human coronaviruses that cause the common cold, we can anticipate that with increased vaccine immunity to SARS-CoV-2, it will become a seasonal, endemic coronavirus that causes less severe disease in most individuals. Much like the common cold CoVs, the potential for severe disease will likely be present in those who lack a protective immune response or are immunocompromised. \|doi-access=free }}</ref> {{as of\|2023}} the transition to endemic COVID-19 may take years or decades.<ref>{{cite journal \|vauthors=Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis NI, Katzourakis A \|title=The evolution of SARS-CoV-2 \|journal=Nat Rev Microbiol \|volume=21 \|issue=6 \|pages=361–379 \|date=June 2023 \|pmid=37020110 \|doi=10.1038/s41579-023-00878-2 \|s2cid=257983412 \|type=Review}}</ref>

	== Long-term effects ==		== Long-term effects ==

COVID-19 pandemic - Revision history

HansBurr9101: /* Cases */ I don't see the point of this {{clear}} template

Xuppi: Cleaned up

Xuppi: Cleaned up

2A02:21B0:644D:B92F:78D6:7F59:F477:3FCC: robot: Trimming article to decrease server load

2A02:21B0:644D:B92F:78D6:7F59:F477:3FCC: robot: Trimming article to decrease server load

2A02:21B0:644D:B92F:78D6:7F59:F477:3FCC: robot: Trimming article to decrease server load

UpdateBot: robot: Update article

>Hunenmensch at 07:29, 20 January 2022

WikiDwarfBOT: clean up, replaced: Wikipedia: → Bharatpedia:

WikiDwarfBOT: /* Other websites */Replace {{Source}} tag